PF-06273340 Uses, Dosage, Side Effects and more
Pf 06273340 is under investigation in clinical trial NCT01934738 (A Study to Evaluate Safety, Toleration and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06273340 in Healthy Subjects of Two AgeGroups, Aged 18-55 Years (Group 1) and Aged 56-75 Years (Group 2)).
Trade Name | PF-06273340 |
Generic | PF-06273340 |
Type | |
Formula | C23H22ClN7O3 |
Weight | Average: 479.93 Monoisotopic: 479.1472653 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |